Perkinsus marinus is a lethal protozoan that impacts eastern oyster (Crassostrea virginica) populations along the eastern seaboard of the United States and the Gulf of Mexico. Despite the potential advantages of a chemical therapy to effectively treat P. marinus infected oysters for aquaculture and research, no such therapy exists. Given the close taxonomic and phylogenetic proximity of P. marinus to another protozoan parasite, Plasmodium spp., the antimalarial drug quinine was evaluated as a potential chemotherapeutic agent. A concentration of 50 μg/mL (0.13 mM) quinine HCl significantly decreased the viability of six geographic isolates of P. marinus after three hours in vitro. Although quinine HCl effectively decreased P. marinus viability, all concentrations tested decreased oyster hemocyte viability in vitro. Furthermore, concentrations below the effective concentration for P. marinus meronts were either lethal to infected oysters or had no observable effect on parasite infections.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.